European Companies Search Engine
Capital: €11.8M · Company statute Hrb6 Dec 2013 German Trade Register Announcements, Germany (29/11/2013)
Overview
Text
STRATEC Biomedical AG, Birkenfeld, Gewerbestr. 37, 75217 Birkenfeld. Due to the conditional increase in the share capital (Conditional Capital I (2007)) decided on May 16, 2007, subscription shares with a par value of EUR 3,550.00 were issued between June 7, 2013 and November 6, 2013; due to the conditional increase in the share capital (Conditional Capital III) decided on June 23, 2006, subscription shares with a par value of EUR 4,200.00 were issued between June 7, 2013 and November 6, 2013; due to the conditional increase in the share capital (Conditional Capital V) decided on May 20, 2009, subscription shares with a par value of EUR 24,750.00 were issued between June 7, 2013 and November 6, 2013. The share capital is thus increased by EUR 32,500.00. On November 25, 2013, the Supervisory Board approved the amendment of the Articles of Association to Section 4 (share capital). Share capital now: EUR 11,770,245.00. The balance of the conditional capital decided on May 16, 2007 (Conditional Capital I (2007)) is still EUR 3,100.00 after partial exhaustion. The balance of the conditional capital (Conditional Capital V) decided on May 20, 2009 is still EUR 173,750.00 after partial exhaustion. The conditional capital (Conditional Capital III) approved at the Annual General Meeting on June 23, 2006 was extinguished by the issuance of subscription shares in the 2013 financial year.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: STRATEC SE, Birkenfeld, Germany.
The visualizations for "STRATEC Biomedical AG - Capital: €11.8M · Company statute"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
